This research looked at how Candesartan and Ramipril affected individuals with chronic hepatitis C’s liver fibrosis. This randomised controlled prospective study included 64 participants with chronic hepatitis C and liver fibrosis. The participants were divided into three groups according to randomization: group I (control group; n=21), which got only...